BeiGene, Ltd. (BGNE)
Last Price$226.70.0%
Market Cap$1,846.9M
(38.4%)
Industry median - (125.1%)
5Y Historical average - (192.4%)
(45.1%)
Industry median - (131.8%)
5Y Historical average - (198.1%)
(25.3%)
Industry median - (52.2%)
5Y Historical average - (38.3%)
(24.7%)
Industry median - (51.2%)
5Y Historical average - (33.9%)
BGNE Capital Allocation Rating
Crunching data... Almost there!
BGNE Capital Allocation metrics
Crunching data... Almost there!
Competing with BGNE Capital Allocation
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the BeiGene, Ltd. (BGNE) ROIC (Return on Invested Capital)?
The BeiGene, Ltd. (BGNE) ROIC is (38.4%), compared to the industry median of ((125.1%)) and the 5-year historical average of (192.4%).
What is the BeiGene, Ltd. (BGNE) ROIC minus WACC (Weighted Average Cost of Capital)?
The BeiGene, Ltd. (BGNE) ROIC minus WACC is (45.1%), compared to the industry median of ((131.8%)) and the 5-year historical average of (198.1%).
What is the BeiGene, Ltd. (BGNE) ROE (Return on Equity)?
The BeiGene, Ltd. (BGNE) ROE is (25.3%), compared to the industry median of ((52.2%)) and the 5-year historical average of (38.3%).
What is the BeiGene, Ltd. (BGNE) ROCE (Return on Capital Employed)?
The BeiGene, Ltd. (BGNE) ROCE is (24.7%), compared to the industry median of ((51.2%)) and the 5-year historical average of (33.9%).